Oncotarget

Corrections:

Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer

PDF  |  How to cite

Oncotarget. 2019; 10:4920-4920. https://doi.org/10.18632/oncotarget.27143

Metrics: PDF 508 views  |   ?  

Mariya Shapovalova1, Julia Davydova2, Christine Henzler3, Mark Daniel4, Scott M. Dehm3, Christopher A. Warlick5 and Aaron M. LeBeau1

1 Department of Pharmacology, University of Minnesota, Minneapolis 55455, MN, USA
2 Department of Surgery, University of Minnesota, Minneapolis 55455, MN, USA
3 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455, MN, USA
4 Department of Microbiology and Immunology, University of Minnesota, Minneapolis 55455, MN, USA
5 Department of Urology, University of Minnesota, Minneapolis 55455, MN, USA

Published: August 06, 2019

This article has been corrected: The proper Grant Support information is shown below:

GRANT SUPPORT

This research was supported by a Department of Defense Prostate Cancer Research Program Early Investigator Research Award – Predoctoral (MS), Prostate Cancer Foundation Young Investigator Award (AML), Randy Shaver Foundation Research Award (AML), Paul Calabresi NCI K12 Award through Mayo Clinic (AML) and an American Cancer Society Institutional Research Grant (AML).

Original article: Oncotarget. 2018; 9:36693–36704. DOI: https://doi.org/10.18632/oncotarget.26401.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27143